{
    "organizations": [],
    "uuid": "504e8b90ce748b9561a43db6b9a6c4ecfeaf62a9",
    "author": "cnbc.com",
    "url": "http://www.cnbc.com/2018/03/07/globe-newswire-novavax-to-host-conference-call-and-webcast-to-provide-corporate-update-and-report-of-fourth-quarter-and-year-end-2017.html",
    "ord_in_thread": 0,
    "title": "Novavax to Host Conference Call and Webcast to Provide Corporate Update and Report of Fourth Quarter and Year-End 2017 Financial Results",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "GAITHERSBURG, Md., Novavax, Inc. (Nasdaq:NVAX) today announced it will provide a corporate update and report its fourth quarter and full year 2017 financial and operating results following the close of U.S. financial markets on Wednesday, March 14, 2018.\nConference call and webcast details are as follows:\nDate: March 14, 2018 Time: 5:00 p.m. U.S. Eastern Time (ET) Dial-in number: (877) 212-6076 (Domestic) or (707) 287-9331 (International) Passcode: 6472939 Webcast: www.novavax.com , “Investors”/ “Events” Conference call and webcast replay: Dates: Starting at 8:00 p.m. ET, March 14, 2018 until 9:00 p.m. ET March 21, 2018 Dial-in number: (855) 859-2056 (Domestic) or (404) 537-3406 (International) Passcode: 6472939 Webcast: www.novavax.com , “Investors”/ “Events”, until June 14, 2018 About Novavax\nNovavax, Inc. (Nasdaq:NVAX) is a clinical-stage biotechnology company committed to delivering novel products to prevent infectious diseases. Our RSV and influenza nanoparticle vaccine candidates are Novavax’ most advanced clinical programs and are at the forefront of the Company’s efforts to improve global health. Additional information about Novavax is available on the Company's website, novavax.com .\nContact:\nInvestors\nWestwicke Partners\nJohn Woolford\njohn.woolford@westwicke.com\n443-213-0506\nMedia\nSam Brown\nMike Beyer\nmikebeyer@sambrown.com\n312-961-2502\nSource:Novavax, Inc.",
    "published": "2018-03-08T00:05:00.000+02:00",
    "crawled": "2018-03-08T03:58:07.000+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "gaithersburg",
        "novavax",
        "nasdaq",
        "nvax",
        "today",
        "announced",
        "provide",
        "corporate",
        "update",
        "report",
        "fourth",
        "quarter",
        "full",
        "year",
        "financial",
        "operating",
        "result",
        "following",
        "close",
        "financial",
        "market",
        "wednesday",
        "march",
        "conference",
        "call",
        "webcast",
        "detail",
        "follows",
        "date",
        "march",
        "time",
        "eastern",
        "time",
        "et",
        "number",
        "domestic",
        "international",
        "passcode",
        "webcast",
        "investor",
        "event",
        "conference",
        "call",
        "webcast",
        "replay",
        "date",
        "starting",
        "et",
        "march",
        "et",
        "march",
        "number",
        "domestic",
        "international",
        "passcode",
        "webcast",
        "investor",
        "event",
        "june",
        "novavax",
        "novavax",
        "nasdaq",
        "nvax",
        "biotechnology",
        "company",
        "committed",
        "delivering",
        "novel",
        "product",
        "prevent",
        "infectious",
        "disease",
        "rsv",
        "influenza",
        "nanoparticle",
        "vaccine",
        "candidate",
        "novavax",
        "advanced",
        "clinical",
        "program",
        "forefront",
        "company",
        "effort",
        "improve",
        "global",
        "health",
        "additional",
        "information",
        "novavax",
        "available",
        "company",
        "website",
        "contact",
        "investor",
        "westwicke",
        "partner",
        "john",
        "woolford",
        "medium",
        "sam",
        "brown",
        "mike",
        "beyer",
        "mikebeyer",
        "source",
        "novavax",
        "inc"
    ]
}